Dr. Alexandre Zanghellini is a co-founder and the Chief Executive Officer of Arzeda Corporation, which combines nature's biological tools and advanced computational design to create innovative cell factors that can transform or supplement current chemical production methods. Alex leads Arzeda’s corporate strategy, including technology and product development. Alex is one of the inventors of Arzeda’s synthetic biology platform for protein design and metabolic pathway design and is a keen believer in the power of biotechnology to solve some of our biggest societal challenges, especially that of transforming industrial and agricultural processes to be more efficient, sustainable and environmentally friendly. Before founding Arzeda, Alex held positions in research and development both in academia and industry (Cellectis, NASDAQ: CLLS). He holds a Ph.D. in Biochemistry from the University of Washington in Seattle WA, a M. Eng. in computer engineering from ENSTA/ParisTech in Paris, France and a M.S in computer science/machine learning from University of Paris VI Pierre et Marie Curie, France.